← Eichor
Condition: Vaccination Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Vaccination

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06907667
Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk
Phase N/A · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT05879965
Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100
Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean
Phase N/A · 1 location(s) · University Hospital Center of Martinique · NCT04839757
Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
Phase 4 · 1 location(s) · University of Sao Paulo General Hospital · NCT07242092
HPV-based Screening Among Women 23-29 Years of Age
NA · 2 location(s) · Karolinska Institutet · NCT05229679
Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients
Phase 1 · 1 location(s) · Mayo Clinic · NCT07317154
Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT07130799
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcino
EARLY_Phase 1 · 2 location(s) · Dana-Farber Cancer Institute · NCT06664151
Normalizing Antibody Detection in First-void Urine
Phase N/A · 1 location(s) · Universiteit Antwerpen · NCT06582654
Antibiotics and Vaccine Immune Responses Study
Phase 4 · 1 location(s) · South Australian Health and Medical Research Institute · NCT06148025
Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After H
Phase 2 · 3 location(s) · Universiteit Antwerpen · NCT07407569
Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
Phase 2 · 3 location(s) · Ever Supreme Bio Technology Co., Ltd. · NCT04115761
Strengthening HPV Immunization Through EPI Leveraged Delivery
Phase 2 · 1 location(s) · International Vaccine Institute · NCT07377656
Serum Collection Study for Assay Development
Phase 1 · 1 location(s) · GPN Vaccines · NCT07205289
Development of an Italian Questionnaire for Splenectomized Patients Using a Delphi Consensus Method
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07428005
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829
Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors
NA · 1 location(s) · University of Utah · NCT07648953
VACcination of LIver Transplantation Candidates
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT04446832
INfluenza VaccInation To Mitigate typE 1 Diabetes
Phase 4 · 10 location(s) · Aarhus University Hospital · NCT05585983
Stories to Prevent (StoP) HPV Cancers
NA · 1 location(s) · Milton S. Hershey Medical Center · NCT06808776
A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue
Phase N/A · 7 location(s) · Takeda · NCT06843226
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
NA · 1 location(s) · Johns Hopkins University · NCT06128928
Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children
Phase 2 · 1 location(s) · International Vaccine Institute · NCT07509047
Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or I
Phase N/A · 2 location(s) · Cardioangiologisches Centrum Bethanien · NCT06650826
TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
Phase 1 · 1 location(s) · University of Maryland, Baltimore · NCT04843852
Clinical and Biological Aspects of the MONKEYPOX Disease
NA · 1 location(s) · Institut Pasteur · NCT05627713
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia
Phase N/A · 2 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06611020
Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT06482450
Impact of Thymectomy on Immunity in Infants After Cardiac Surgery
NA · 2 location(s) · Nantes University Hospital · NCT07019857
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.